Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide. (2021)

First Author: Chowdhury O
Attributed to:  Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-020-0979-6

PubMed Identifier: 32770086

Publication URI: http://europepmc.org/abstract/MED/32770086

Type: Journal Article/Review

Volume: 35

Parent Publication: Leukemia

Issue: 4

ISSN: 0887-6924